Glucagon-like peptide-1 receptor agonists exhibit weight loss effects in non-diabetic patients with obesity
1. This systematic review found that non-diabetic patients with obesity who received glucagon-like peptide-1 receptor agonists (GLP-1RAs) had significantly reduced ...